John Hester
Stock Analyst at Bell Potter
(4.07)
# 1,585
Out of 4,339 analysts
196
Total ratings
49%
Success rate
9.4%
Average return
Main Sectors:
Stocks Rated by John Hester
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: ARX Aroa Biosurgery Limited | Maintained: Buy | $1.12 → $1.09 | $0.635 | +71.65% | 6 | May 26, 2026 | |
| ASX: DOC Doctor Care Anywhere Group PLC | Upgraded: Buy | $0.20 → $0.24 | $0.13 | +84.62% | 4 | May 21, 2026 | |
| ASX: IMU Imugene Limited | Maintained: Buy | $0.25 | $0.115 | +117.39% | 6 | May 15, 2026 | |
| ASX: CYC Cyclopharm Limited | Maintained: Buy | $1.00 | $0.70 | +42.86% | 13 | May 10, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Maintained: Buy | $19.00 | $13.69 | +38.84% | 31 | May 8, 2026 | |
| ASX: MSB Mesoblast Limited | Maintained: Buy | $4.45 | $2.12 | +110.40% | 18 | May 1, 2026 | |
| ASX: PME Pro Medicus Limited | Maintained: Buy | $240.00 → $226.00 | $130.47 | +73.23% | 15 | Apr 14, 2026 | |
| ASX: CU6 Clarity Pharmaceuticals Ltd | Maintained: Buy | $6.40 → $6.50 | $2.67 | +143.90% | 19 | Apr 1, 2026 | |
| ASX: PGC Paragon Care Limited | Maintained: Buy | $0.29 → $0.30 | $0.14 | +114.29% | 16 | Mar 30, 2026 | |
| ASX: AVR Anteris Technologies Global Corp. | Maintained: Buy | $10.00 → $13.00 | $12.45 | +4.42% | 4 | Mar 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.00 | $2.85 | +5.45% | 4 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $4.10 → $3.60 | $3.15 | +14.29% | 16 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.00 → $1.80 | $1.23 | +46.94% | 11 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.50 → $4.50 | $3.50 | +28.57% | 12 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.05 → $0.06 | $0.02 | +200.00% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.73 → $0.65 | $0.165 | +293.94% | 9 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.18 → $0.15 | $0.048 | +212.50% | 2 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.01 | $0.005 | n/a | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.90 → $3.87 | $3.90 | n/a | 3 | Nov 25, 2022 |
Aroa Biosurgery Limited
May 26, 2026
Maintained: Buy
Price Target: $1.12 → $1.09
Current: $0.635
Upside: +71.65%
Doctor Care Anywhere Group PLC
May 21, 2026
Upgraded: Buy
Price Target: $0.20 → $0.24
Current: $0.13
Upside: +84.62%
Imugene Limited
May 15, 2026
Maintained: Buy
Price Target: $0.25
Current: $0.115
Upside: +117.39%
Cyclopharm Limited
May 10, 2026
Maintained: Buy
Price Target: $1.00
Current: $0.70
Upside: +42.86%
Telix Pharmaceuticals Limited
May 8, 2026
Maintained: Buy
Price Target: $19.00
Current: $13.69
Upside: +38.84%
Mesoblast Limited
May 1, 2026
Maintained: Buy
Price Target: $4.45
Current: $2.12
Upside: +110.40%
Pro Medicus Limited
Apr 14, 2026
Maintained: Buy
Price Target: $240.00 → $226.00
Current: $130.47
Upside: +73.23%
Clarity Pharmaceuticals Ltd
Apr 1, 2026
Maintained: Buy
Price Target: $6.40 → $6.50
Current: $2.67
Upside: +143.90%
Paragon Care Limited
Mar 30, 2026
Maintained: Buy
Price Target: $0.29 → $0.30
Current: $0.14
Upside: +114.29%
Anteris Technologies Global Corp.
Mar 8, 2026
Maintained: Buy
Price Target: $10.00 → $13.00
Current: $12.45
Upside: +4.42%
Feb 27, 2026
Maintained: Hold
Price Target: $3.00
Current: $2.85
Upside: +5.45%
Feb 24, 2026
Upgraded: Hold
Price Target: $4.10 → $3.60
Current: $3.15
Upside: +14.29%
Feb 23, 2026
Maintained: Buy
Price Target: $2.00 → $1.80
Current: $1.23
Upside: +46.94%
Feb 2, 2026
Maintained: Buy
Price Target: $2.50 → $4.50
Current: $3.50
Upside: +28.57%
Dec 17, 2025
Maintained: Buy
Price Target: $0.05 → $0.06
Current: $0.02
Upside: +200.00%
Sep 30, 2025
Maintained: Buy
Price Target: $0.73 → $0.65
Current: $0.165
Upside: +293.94%
Sep 3, 2025
Downgraded: Hold
Price Target: $0.18 → $0.15
Current: $0.048
Upside: +212.50%
Dec 19, 2024
Downgraded: Hold
Price Target: $0.01
Current: $0.005
Upside: n/a
Nov 25, 2022
Maintained: Hold
Price Target: $4.90 → $3.87
Current: $3.90
Upside: n/a